Search research articles
Contact Us
Filters
Showing results (1-10 of 220) with videos related to
Page
of 22
Sort By:
Bulletin De L'Academie Nationale De Medecine
|
August 2, 2016
[Pharmacoepidemiology: an another kind of drug surveillance]
Antoine Pariente
Therapie
|
April 3, 2023
Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?
Antoine Pariente
European Heart Journal
|
October 17, 2025
Pharmacoepidemiology as the delicate science of constructing robust plausibility where there is no certainty: the case for hypertension in young adults
Antoine Pariente
La Revue Du Praticien
|
January 16, 2014
[Analyze and use the results of clinical studies in the context of good use. Critical analysis, clinical research and levels of evidence]
Antoine Pariente
Therapie
|
June 13, 2021
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
Antoine Pariente, Julien Bezin
Drug Safety
|
September 16, 2021
Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse
Priya Bahri, Antoine Pariente
Therapie
|
March 2, 2019
Methods in pharmacoepidemiology
Agnès Sommet, Antoine Pariente
Neurology
|
July 5, 2024
Reader Response: Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study
Charles Khouri, Antoine Pariente
Therapie
|
April 28, 2018
[Understanding the distrust towards the assessment of medicines. Beyond conflict of interests]
Virginie Tournay, Antoine Pariente
La Revue Du Praticien
|
February 23, 2023
[Analyze and use the results of clinical studies in the perspective of good use. Critical analysis, clinical research and levels of evidence]
Antoine Pariente, Sibylle de Germay
Page
of 22
Search research articles
Search
Showing results (1-10 of 220) with videos related to
Sort By:
Page
of 22
Bulletin De L'Academie Nationale De Medecine
|
August 2, 2016
[Pharmacoepidemiology: an another kind of drug surveillance]
Antoine Pariente
Therapie
|
April 3, 2023
Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?
Antoine Pariente
European Heart Journal
|
October 17, 2025
Pharmacoepidemiology as the delicate science of constructing robust plausibility where there is no certainty: the case for hypertension in young adults
Antoine Pariente
La Revue Du Praticien
|
January 16, 2014
[Analyze and use the results of clinical studies in the context of good use. Critical analysis, clinical research and levels of evidence]
Antoine Pariente
Therapie
|
June 13, 2021
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
Antoine Pariente, Julien Bezin
Drug Safety
|
September 16, 2021
Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse
Priya Bahri, Antoine Pariente
Therapie
|
March 2, 2019
Methods in pharmacoepidemiology
Agnès Sommet, Antoine Pariente
Neurology
|
July 5, 2024
Reader Response: Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study
Charles Khouri, Antoine Pariente
Therapie
|
April 28, 2018
[Understanding the distrust towards the assessment of medicines. Beyond conflict of interests]
Virginie Tournay, Antoine Pariente
La Revue Du Praticien
|
February 23, 2023
[Analyze and use the results of clinical studies in the perspective of good use. Critical analysis, clinical research and levels of evidence]
Antoine Pariente, Sibylle de Germay
Page
of 22